Retinoid-induced limb defects 2: involvement of TGF-beta 2 in retinoid-induced inhibition of limb bud development

H Tsuiki1, K Kishi

  • 1Developmental Research Laboratories, Shionogi & Co., Toyonaka, Osaka, Japan. hisashi.tsuiki@shionogi.co.jp

Insights

All-trans-retinoic acid (RA) inhibits forelimb bud development by increasing TGF-beta2, a growth factor. This study confirms TGF-beta2

Area of Science:

  • Developmental Biology
  • Teratology
  • Molecular Biology

Background:

  • Retinoids are crucial for embryonic development.
  • Retinoic acid (RA) can cause birth defects, including limb malformations.
  • Transforming growth factor-beta2 (TGF-beta2) is implicated in retinoid-induced chondrogenesis inhibition.

Purpose of the Study:

  • To investigate the role of TGF-beta2 in all-trans-retinoic acid (RA)-induced inhibition of forelimb bud development.
  • To elucidate the mechanism by which RA affects TGF-beta2 expression and function in developing limbs.

Main Methods:

  • Immunohistochemistry to detect TGF-beta2 expression in rat embryonic forelimb buds.
  • Whole embryo culture to assess the effects of RA and TGF-beta2 on limb growth and protein content.
  • In vitro cell culture to study the impact of TGF-beta2 on DNA synthesis.
  • Antibody neutralization to block TGF-beta2 activity.

Main Results:

  • RA administration increased TGF-beta2 expression in specific regions of the forelimb bud, including the distal margin and prechondrogenic areas.
  • RA reduced forelimb bud growth and protein content in a dose-dependent manner.
  • Exogenous TGF-beta2 inhibited limb growth, protein content, and DNA synthesis.
  • Neutralization of TGF-beta2 partially rescued RA-induced limb growth inhibition.

Conclusions:

  • RA-induced TGF-beta2 in the distal margin contributes to reduced cell proliferation and forelimb bud growth inhibition.
  • RA-induced TGF-beta2 in prechondrogenic areas may inhibit chondrogenesis, leading to forearm bone defects.
  • TGF-beta2 is a key mediator in RA-induced limb malformations.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...